WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

6.24.26

Wilson Sonsini Advises Assort Health on $120 Million Series C
On June 24, 2026, Assort Health, the most widely used AI agents platform for the patient journey, announced a $120 million Series C led by Menlo Ventures at a valuation of $1.2 billion. Assort has now raised more than $222 million to become the standard for healthcare organizations wanting to transform the patient journey with AI. Wilson Sonsini Goodrich & Rosati advised Assort on the transaction.

In addition to Menlo Ventures, investors participating in the Series C financing include Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital.  

What began as the first voice AI agent to schedule a specialty appointment is now a platform spanning scheduling, intake forms, referrals, document processing, medication refills, real time eligibility, lab requests, and payments. That expansion has been powered by more than 190 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways, creating the largest proprietary specialty dataset in healthcare. 

The Wilson Sonsini team that advised Assort on the financing included Lang Liu, Alex Youssef, Madisyn Klein, and Nara Jo.

For more information, please see Assort’s blog post.
Client Highlights

5.13.26

Wilson Sonsini Advises Recursive on $650 Million Series A Funding at a $4.65 Billion Valuation
On May 13, 2026, Recursive, an AI start-up dedicated to advancing AI intelligence through recursive self-improvement, came out of stealth and announced that it raised over $650 million in its Series A round at a $4.65 billion valuation. The funding round was led by Google Ventures and Greycroft, with participation from chip makers AMD Ventures and NVIDIA. Wilson Sonsini Goodrich & Rosati advised Recursive on the transaction.
Client Highlights

2.05.26

Wilson Sonsini Advises Adaption Labs on $50 Million Seed Funding
On February 4, 2026, Adaption Labs, a start-up building AI systems that evolve through real world interaction, enabling efficient AI across domains, languages, and operational constraints, announced it has raised $50 million in a seed funding round led by Emergence Capital Partners, with participation from Mozilla Ventures, Fifty Years, Threshold Ventures, Alpha Intelligence Capital, E14 Fund, and Neo. Wilson Sonsini Goodrich & Rosati advised Adaption Labs on the transaction.
Client Highlights

12.19.25

Wilson Sonsini Advises Cursor on Acquisition of Graphite
On December 19, 2025, Cursor, the leading AI development platform, announced that it has signed a definitive agreement to acquire Graphite, a start-up that uses AI to review code. The financial terms of the deal were not disclosed. Wilson Sonsini Goodrich & Rosati advised Cursor on the transaction.

The transaction brings together best-in-class tools for creating, reviewing, and merging code in the AI age. Graphite will continue to operate independently, with the same team and product. According to Cursor, in the coming months the two companies will explore connecting their products, for instance with tighter integrations between local development and pull requests and smarter code review that learns from both systems.

The Wilson Sonsini team that advised Cursor on the transaction included:

M&A
Rich Mullen
Ryan Cooper
Hallee Moore
Valerie Lopez
Drew Downing
Client Highlights

9.30.25

Wilson Sonsini Advises Assort Health on $76 Million Series B
On September 30, 2025, Assort Health, a comprehensive patient experience platform powered by specialty-specific agentic AI, announced the close of a $76 million Series B financing round led by Lightspeed Venture Partners, with investments by Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet. A Wilson Sonsini Goodrich & Rosati team led by Lang Liu, Alex Youssef, and Andrew Lu advised Assort Health on the transaction.
Client Highlights

9.19.25

Wilson Sonsini Advises Anysphere on Acquisition of Koala
Anysphere, the company behind the artificial intelligence coding application Cursor, acquired Koala, an AI-powered customer relationship management start-up. The acquisition brings Koala’s top engineers to Cursor to help build out a dedicated enterprise-readiness team. Wilson Sonsini Goodrich & Rosati advised Anysphere on the transaction.
Client Highlights

8.12.25

Wilson Sonsini Advises Dealops on $7 Million Financing
On August 12, 2025, Dealops, a start-up building AI pricing infrastructure for enterprise sales teams, announced successfully raising $7 million in seed and pre-seed funding, led by Pear VC and General Catalyst, with participation from Depth Capital Ventures, Elsa Capital, Weekend Fund, Flex Capital, Allison Pickens, 20Sales and a range of individual leaders from companies including OpenAI, Anthropic, Stripe, and Salesforce. Wilson Sonsini Goodrich & Rosati advised Dealops on the transaction.
Client Highlights

8.06.25

Wilson Sonsini Advises Skylight Health on $13 Million Fundraise
On August 4, 2025, Skylight Health, a healthcare company committed to improving specialty care for everyone, announced the closing of $13 million in aggregate financing led by Valtruis, with participation from Andreessen Horowitz (a16z) and Allen & Company LLC. Wilson Sonsini Goodrich & Rosati advised Skylight Health on the fundraise.
Client Highlights

7.29.25

Wilson Sonsini Advises Monumental Labs on $8 Million Financing
On July 21, 2025, Monumental Labs, an AI-powered robotic fabrication platform, announced successfully raising over $8 million, most recently in a financing round led by Seven Seven Six with participation from Mythos Ventures, Sahil Lavingia, Gravity Capital, Path Ventures, Milstein Companies, and Inflection. Wilson Sonsini Goodrich & Rosati advised Monumental Labs on the transaction.
Client Highlights

7.24.25

Wilson Sonsini Advises Memories.ai on $8 Million Seed Financing
On July 24, 2025, Memories.ai, an AI research lab building visual memories for AI, announced that it has raised $8 million in a seed funding round led by Susa Ventures, with participation from Samsung Next, Crane Venture Partners, Fusion Fund, Seedcamp, and Creator Ventures. Wilson Sonsini Goodrich & Rosati advised Memories.ai on the transaction.
Client Highlights

7.02.25

Wilson Sonsini Advises Grammarly on Acquisition of Superhuman
On July 1, 2025, Grammarly, the trusted AI assistant for communication and productivity, announced its intent to acquire Superhuman, an AI-native email platform that helps users respond one to two days faster and save four hours per week on email communications. Wilson Sonsini Goodrich & Rosati is advising Grammarly on the transaction.
Client Highlights

6.03.25

Wilson Sonsini Advises Palmstreet on Fundraising Transactions
On May 21, 2025, Plant Identification, Inc. (d/b/a Palmstreet), a live-shopping marketplace, announced it has raised $25 million in aggregate funding from investors such as a16z, Craft Ventures, and Headline, along with other early-stage investors. Wilson Sonsini Goodrich & Rosati has represented Palmstreet in its recent financing transactions.
  • 1
  • 2
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.